Tennessee Oncology (Sarah Cannon) — Nashville, Tennessee

Tennessee Oncology (Sarah Cannon) is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Tennessee Oncology (Sarah Cannon) has participated in 1 clinical trials.

Therapeutic areas: Triple Negative Breast Cancer.

Sponsors: Zenith Epigenetics.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tennessee Oncology (Sarah Cannon)?

Tennessee Oncology (Sarah Cannon) has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tennessee Oncology (Sarah Cannon) conducted?

Tennessee Oncology (Sarah Cannon) has 1 clinical trials on record. Their work covers Triple Negative Breast Cancer.

Is Tennessee Oncology (Sarah Cannon) accredited by Crixeo Health?

Tennessee Oncology (Sarah Cannon) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tennessee Oncology (Sarah Cannon)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.